FRI0186 Long-term safety and efficacy of 4-weekly certolizumab pegol monotherapy and combination therapy in rheumatoid arthritis: 5-year results from an open-label extension study

Fleischmann, R. ; van Vollenhoven, R. ; Vencovsky, J. ; Alten, R. ; Davies, O. ; Stach, C. ; de Longueville, M. ; VanLunen, B. ; Choy, E.

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A435-A435 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd and European League Against Rheumatism

Texto completo disponível